Literature DB >> 27178483

A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia.

Kakali Ghoshal1, Sangita Das2, Krishnendu Aich2, Shyamaprosad Goswami2, Subhankar Chowdhury3, Maitree Bhattacharyya4.   

Abstract

BACKGROUND: Oxidative stress is common in type 2 diabetes. It is characterised by increased levels of reactive oxygen species (ROS), of which hypochlorous acid (HOCl) is an important component. Type 2 diabetes is characterised not only by hyperglycemia, but also by dyslipidemia. It probably underlies both the development of diabetes and also resulting complications, like cardiovascular disease. We applied a novel fluoroprobe RHQ to estimate endogenous HOCl and myeloperoxidase (MPO) activity in diabetes and dyslipidemia.
METHODS: Our newly designed probe, RHQ (rhodamine-quinoline based chemodosimeter) is capable of estimating endogenous HOCl selectively out of the ROS components. Isolated leukocytes from study subjects were treated with DCFDA and monocytes and neutrophils with RHQ for estimating endogenous ROS and HOCl respectively. Plasma AOPP, an indicator of HOCl was also measured. We attempted to find out the key reasons of higher HOCl content in diabetic dyslipidemic subjects by quantitating endogenous hydrogen peroxide (H2O2) and myeloperoxidase (MPO) activity.
RESULTS: Isolated PBMCs from diabetic dyslipidemic subjects indicated enhanced ROS and HOCl generation followed by diabetic subjects without dyslipidemia and healthy controls. We explored increased production of H2O2 and enhanced enzymatic activity of myeloperoxidase (MPO) among diabetic dyslipidemic subjects (p<0.0001) resulting in higher HOCl content.
CONCLUSION: The hyperglycemic and hyperlipidemic challenges together enhance the production of HOCl and the fluoroprobe RHQ may be used as a novel diagnostic marker to evaluate the extent of this toxicity.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Dyslipidemia; Fluorescent probe; Hypochlorous acid; Reactive oxygen species (ROS)

Mesh:

Substances:

Year:  2016        PMID: 27178483     DOI: 10.1016/j.cca.2016.05.006

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

1.  Adiponectin Genetic Variant and Expression Coupled with Lipid Peroxidation Reveal New Signatures in Diabetic Dyslipidemia.

Authors:  Kakali Ghoshal; Tanima Chatterjee; Subhankar Chowdhury; Sanghamitra Sengupta; Maitree Bhattacharyya
Journal:  Biochem Genet       Date:  2021-02-04       Impact factor: 1.890

Review 2.  Effects of Moringa oleifera aqueous leaf extract in alloxan induced diabetic mice.

Authors:  Muobarak J Tuorkey
Journal:  Interv Med Appl Sci       Date:  2016-09

3.  Lycopene Improves the Metformin Effects on Glycemic Control and Decreases Biomarkers of Glycoxidative Stress in Diabetic Rats.

Authors:  Ingrid Delbone Figueiredo; Tayra Ferreira Oliveira Lima; Maiara Destro Inácio; Mariana Campos Costa; Renata Pires Assis; Iguatemy Lourenço Brunetti; Amanda Martins Baviera
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-07       Impact factor: 3.168

Review 4.  The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.

Authors:  Tawar Qaradakhi; Laura Kate Gadanec; Kristen Renee McSweeney; Jemma Rose Abraham; Vasso Apostolopoulos; Anthony Zulli
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

5.  Valeriana rigida Ruiz & Pav. Root Extract: A New Source of Caffeoylquinic Acids with Antioxidant and Aldose Reductase Inhibitory Activities.

Authors:  Guanglei Zuo; Hyun-Yong Kim; Yanymee N Guillen Quispe; Zhiqiang Wang; Kang-Hyuk Kim; Paul H Gonzales Arce; Soon-Sung Lim
Journal:  Foods       Date:  2021-05-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.